2014
DOI: 10.1016/j.biomaterials.2014.04.050
|View full text |Cite
|
Sign up to set email alerts
|

Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 47 publications
(35 citation statements)
references
References 32 publications
0
34
0
1
Order By: Relevance
“…LHTD4 was then synthesized by end-site conjugation of LHT7 with tetraDOCA following the previous procedure [10]. At first, LHT7 was oxidized by using potassium metaperiodate (57.5 mg) in acetate buffer at pH 4.5.…”
Section: Synthesis and Characterization Of Lht7 Lhtd4 And Dckmentioning
confidence: 99%
See 1 more Smart Citation
“…LHTD4 was then synthesized by end-site conjugation of LHT7 with tetraDOCA following the previous procedure [10]. At first, LHT7 was oxidized by using potassium metaperiodate (57.5 mg) in acetate buffer at pH 4.5.…”
Section: Synthesis and Characterization Of Lht7 Lhtd4 And Dckmentioning
confidence: 99%
“…These properties of LHT7 contribute to the selective blocking of interactions with ATIII while enhancing its binding with VEGF and bFGF. Furthermore, in order to administer LHT7 via oral route, we synthesized LHTD4 by conjugating LHT7 with a newly developed bile acid-derived moiety that consists of 4 molecules of deoxycholic acid (tetraDOCA) [10]. We saw that this conjugation imposed high binding affinity to membrane transporters on LHTD4, enabling it to be orally absorbed through the apical sodium-dependent bile acid transporter (ASBT)-mediated pathway [11,12].…”
Section: Introductionmentioning
confidence: 98%
“…[12][13][14][15] In the case of CS, the preparation of self-assembling micelles as the drug carrier system was developed based on the conjugation with α-linoleic acid. 16) In addition, novel nanomaterials are being developed to improve the oral bioavailability of low molecular mass compounds, proteins, and recombinant DNAs.…”
Section: 3)mentioning
confidence: 99%
“…[12][13][14][15] However, there are two issues for evaluation of PIC generated in this study. One is the toxicity of extracellular SPM because amine oxidase in fetal calf serum produces aminodialdehyde-generating acrolein.…”
Section: Effect Of the Molecular Size Of Cs On Pic Formation Efficiencymentioning
confidence: 99%
“…Oral BA: hardly absorbed (Chen et al, 2009) Positively charged nanoparticles (chitosan with a low MW of 30 kDa): increased oral BA, 20.5% (rats) (Chen et al, 2009) Low-MW heparin A highly sulfated glycosaminoglycans; MW, less than 8 kDa Injection: t 1/2 , 0.57-4 h (Samama & Gerotziafas, 2000;Hwang et al, 2012). Oral BA: hardly absorbed (Dong et al, 2007;Hwang et al, 2012;Alam et al, 2014); 1.6% (monkeys) and 7.4% (rats) (Alhilal et al, 2014) Positively charged nanoparticles (poly(e-caprolactone)/Eudragit V R RS,1:1): increased oral BA, 51-59% (rabbits); prolonged anticoagulant effect, 8-11.5 h (Hoffart et al, 2006) Conjugation (DA): increased oral BA, $16% (mice) (Dong et al, 2007) Conjugation (dimeric DA): increased oral BA, 19.3% (rats) (Hwang et al, 2012) Conjugation (T-DA): increased oral BA, 19.9% (monkeys) and 33.5% (rats) (Alhilal et al, 2014) Conjugation (T-DA)þcomplexation (DCEA): increased oral BA, 34.3% (rats); prolonged MRT, 7.5 h; improved antiangiogenic efficacy Chinese yam PS A neutral PS composed of glucose and galactose (1.52:1, molar ratio); MW, 16.6 kDa (Yang et al, 2015) PLGA nanoparticles: slowed release and improved immunomodulatory activity in vitro (Luo et al, 2016 et al, 2016a). Overall, ROPS-loaded liposomes (ROPS-Ls) showed significantly better efficacy than free ROPS.…”
Section: Synergistic Immunomodulatory Effectsmentioning
confidence: 99%